Intima Bioscience
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Intima Bioscience is a biotechnology company that develops gene and cell therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intima Bioscience Comparables
Compare Intima Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affini-T Therapeutics | 82% | |
| Obsidian Therapeutics | 81% | |
| Grit Biotherapeutics | 80% |
Intima Bioscience Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 103% MoM, reaching 1.2K.
- May 4, 2025
Monthly visitors grew 159% MoM, reaching 1.2K.
Intima Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Intima Bioscience's valuation, stock price, and market status.
Is Intima Bioscience a public or private company?
Intima Bioscience is a private company.
What is the current stock price of Intima Bioscience?
Intima Bioscience is a private company, so its shares have no public market price. Caplight tracks Intima Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Intima Bioscience worth (valuation)?
Valuation information for Intima Bioscience is not publicly available.
Can I buy Intima Bioscience stock?
Intima Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Intima Bioscience's last funding round?
Funding round information for Intima Bioscience is not publicly available.
Who are the main investors in Intima Bioscience?
Investor information for Intima Bioscience is not publicly disclosed.
Will Intima Bioscience IPO soon?
No public IPO plans have been announced for Intima Bioscience.
How can I track Intima Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Intima Bioscience's shares on secondary markets.